N/A N=24 MBCT Intervention: Healthy Mind, Healthy Living
Mindfulness Based Cognitive Therapy · Depression · Sleep
Primary: Depression — 10.29 score
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=52 Smartphone-based Self-care Education Program for Women With Interstitial Cystitis: Educational Remote IC Aide
Cystitis, Interstitial
Primary: Change in Pain Self Efficacy Scale — 10 score on a scale — p=<0.001
Phase 1 N=12 A Study to Learn About the Study Medicine Called Zavegepant in Healthy Chinese Adult Participants
Healthy
Primary: Cmax of Zavegepant in Plasma Following Single Dose of Zavegepant 10 mg IN — 20.32 nanogram per milliliter (ng/mL)
N/A N=13 Efficacy of a Multimodal Brain Health Intervention for Older African Americans
Cognitive Impairment, Mild · Cognitive Decline
Primary: Daily Average Steps Recorded by Actigraphy Watch — 2570; 1140 daily step count
N/A N=18 Jewel Electrophysiology (EP) Lab Study
Sudden Cardiac Arrest
Primary: Clinical Effectiveness of the Jewel — 16 Participants
N/A N=31 Diet and Hypertension Management in African Americans With Chronic Kidney Disease
Chronic Kidney Diseases · High Blood Pressure
Primary: Number of Group Counseling Sessions Attended by Participants Randomized to the Treatment Arm — 8.9 sessions per participant
N/A N=28 High Purity Type I Collagen Based Skin Substitute Vs Dehydrated Human Amnion/Chorion Membrane in Treatment of DFUs
Diabetic Foot Ulcer (DFU)
Primary: Percentage Wound Area Epithelialization From Week 1 Through 4 — 93.62; 77.71 percentage wound area epithelialization
Phase 1 N=11 Study of AMG 994 Monotherapy and AMG 994 and AMG 404 Combination Therapy in Participants With Advanced Solid Tumors
Advanced Solid Tumors
Primary: Number of Participants Who Experienced Dose Limiting Toxicities (DLTs) — 0; 3 Number of participants
N/A N=144 Study to Evaluate the Efficacy of Intranasal Kinetic Oscillation Stimulation in the Preventive Treatment of Chronic Migraine
Chronic Migraine
Primary: Mean Change From Baseline (4-week Screening Period) in Monthly Headache Days With Moderate to Severe Intensity in 4-week Performance Assessment Period. — -3.45; -1.22…
Phase 1 N=56 A Phase 1 Study Investigating the Safety, Tolerability and Pharmacokinetics of KNX100 in Healthy Volunteers
Healthy Volunteer Study · Opioid-use Disorder
Primary: Proportion of Participants With TEAEs — 1; 1; 2; 0 Participants
N/A N=27 Gene Expression, Meditative Movement, and Emotional Distress (GME)
Cognitive Impairment
Primary: Perceived Cognitive Impairments (CogPCI) — 17.3 units on a scale — p=.01
N/A N=97 Decision Aid for Education and Support About Cancer Treatment
Cancer · Childhood Cancer
Primary: Acceptability of Decision Aid — 4.10; 4.06; 4.01; 4.13 Average Score on a Scale
N/A N=1,623 Comparative Effectiveness of Peripheral Nerve Blocks for Outpatient Shoulder Surgery
Postoperative Complications
Primary: Postoperative Complication — 130; 23; 20; 12 Participants
Phase 2 N=9 Tagraxofusp (SL-401) in Participants With Chronic Myelomonocytic Leukemia (CMML) and Myelofibrosis (MF)
Myelofibrosis · Chronic Myelomonocytic Leukemia
Primary: Number of Participants With Dose-limiting Toxicities (DLTs) — 0; 0; 0; 0 participants
Phase 1 N=27 Safety, Tolerability, and Pharmacokinetics of SAB-176 in Healthy Participants
Influenza Type A · Influenza Type B · Influenza
Primary: Number of Participants Having Adverse Events — 0; 1; 1; 1 Participants